Moreover, antiestrogen resistant breast cancer cells MCF7/LCC9 have greater BCL2 protein expression compared to antiestrogen sensitive breast cancer cells (MCF7/LCC1) [68]. This evidence concerns the gene BCL2 and breast carcinoma.